XENE icon

Xenon Pharmaceuticals

174 hedge funds and large institutions have $2.36B invested in Xenon Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 57 increasing their positions, 56 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

2% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 56

0.52% less ownership

Funds ownership: 97%96.48% (-0.52%)

13% less funds holding in top 10

Funds holding in top 10: 87 (-1)

Holders
174
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.17M
Puts
$3.07M
Net Calls
Net Calls Change

Top Sellers

1 -$24.1M
2 -$23.4M
3 -$14.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$13.7M
5
Norges Bank
Norges Bank
Norway
-$13.1M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$200M
2
$189M
3
$183M
4
$116M
5
$89.4M
6
$89.3M
7
$87.6M
8
$78.3M
9
$75.4M
10
$71M
11
$70.4M
12
$70.4M
13
$47.1M
14
$45.4M
15
$43.1M
16
$42.2M
17
$40.5M
18
$38.3M
19
$38.1M
20
$36.2M
21
$30.5M
22
$29M
23
$28.9M
24
$27.4M
25
$27.2M